Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
Article in Cancer Letters (February 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
The hidden architects of glioblastoma multiforme: Glioma stem cells
Article in MedComm – Oncology (February 2024)
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
Article in Journal of Medicinal Chemistry (January 2024)